Breast Cancer Screening and Prevention

CONTENTS......Page 5
PREFACE......Page 7
ABSTRACT......Page 11
INTRODUCTION......Page 13
CHEMOPREVENTION......Page 14
NSABP......Page 15
ROYAL MARSDEN HOSPITAL (RMH)......Page 16
IBIS-I (INTERNATIONAL BREAST INCIDENCE STUDY)......Page 17
RUTH......Page 18
FURTHER AREAS TO BE INVESTIGATED......Page 19
STRATEGIES IN PATIENTS CARRYING 
BRCA1/BRCA2 MUTATIONS......Page 21
ANTI-TUMOUR AGENTS......Page 22
LIFESTYLE CHANGES......Page 23
REFERENCES......Page 24
HEALTH BELIEFS AND BREAST CANCER SCREENING: APPLYING THE STAGE-OF-CHANGE MODELS......Page 31
ABSTRACT......Page 32
1. INTRODUCTION......Page 33
2.2. Sample......Page 36
2.4. Variables and Instruments......Page 37
3. RESULTS......Page 39
3.1. Differences between Stages in Sociocognitive Variables......Page 40
3.2. Differences between Stages in the Perceived 
Benefits Items......Page 41
3.3. Differences between Stages in the Perceived 
Barriers Items......Page 48
3.4. Differences between Stages and Items  \rof the Information Scale......Page 49
CONCLUSIONS......Page 50
APPENDIX 1......Page 58
REFERENCES......Page 60
INTRODUCTION......Page 68
Study Design......Page 70
Theoretical Underpinnings......Page 71
Data Management and Statistical Analysis......Page 72
RESULTS......Page 73
Breast Cancer Knowledge......Page 75
Breast Cancer Perceptions......Page 77
Logistic Regression......Page 78
DISCUSSION......Page 81
REFERENCES......Page 83
ACCESS TO MAMMOGRAPHY FACILITIES AND DETECTION OF BREAST CANCER BY SCREENING MAMMOGRAPHY: A GIS APPROACH......Page 87
ABSTRACT......Page 88
INTRODUCTION......Page 89
Data Collection......Page 90
Calculation of Access to Mammography Facility......Page 91
Statistical Analysis to Examine Relationship between  \rthe Variables......Page 92
Demographic Characteristics......Page 93
DISCUSSION......Page 97
REFERENCES......Page 101
ACCESS TO MAMMOGRAPHY FACILITIES AND BREAST CANCER STAGE AT DIAGNOSIS: DOES GEOGRAPHIC  \rDISTANCE PREDICT?......Page 105
ABSTRACT......Page 106
INTRODUCTION......Page 107
METHODS......Page 108
Statistical Analysis to Examine Relationship between 
the Variables......Page 109
Demographic Characteristics......Page 110
DISCUSSION......Page 118
REFERENCES......Page 119
 
REDUCTION IN THE RISK OF HUMAN 
BREAST CANCER BY SELECTIVE 
CYCLOOXYGENASE-2 (COX-2) 
INHIBITORS: FINAL RESULTS 
OF A CASE CONTROL STUDY......Page 123
Conclusions......Page 124
METHODS......Page 126
RESULTS......Page 127
DISCUSSION......Page 130
ACKNOWLEDGMENTS......Page 131
REFERENCES......Page 132
INDEX......Page 135